Abivax Files September 2024 6-K Report
Ticker: AAVXF · Form: 6-K · Filed: Sep 25, 2024 · CIK: 1956827
| Field | Detail |
|---|---|
| Company | Abivax S.A. (AAVXF) |
| Form Type | 6-K |
| Filed Date | Sep 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Abivax filed its monthly 6-K, confirming 20-F annual report filing and providing Paris HQ details.
AI Summary
Abivax S.A. filed a Form 6-K on September 25, 2024, to report its activities for the month of September 2024. The filing indicates that Abivax is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive offices are located at 7-11 boulevard Haussmann, 75009 Paris, France.
Why It Matters
This filing provides routine updates on Abivax's activities as a foreign private issuer, which is important for investors tracking the company's regulatory compliance and reporting schedule.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Abivax S.A. (company) — Registrant
- 7-11 boulevard Haussmann, 75009 Paris, France (location) — Principal executive office address
FAQ
What type of filing is Abivax S.A. submitting?
Abivax S.A. is submitting a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
For what period is this Form 6-K reporting?
This Form 6-K is for the month of September 2024.
Does Abivax file annual reports under Form 20-F or 40-F?
Abivax indicates it files annual reports under cover of Form 20-F.
What is the address of Abivax's principal executive offices?
The address of Abivax's principal executive offices is 7-11 boulevard Haussmann, 75009 Paris, France.
What is the telephone number for Abivax's principal executive offices?
The telephone number for Abivax's principal executive offices is +33 (0) 1 53 83 08 41.
Filing Stats: 189 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-09-25 16:30:10
Filing Documents
- f6k_092524.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 11KB
- 0001171843-24-005354.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Abivax SA (Registrant) Date: September 25, 2024 /s/ Marc de Garidel Marc de Garidel Chief Executive Officer